UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042024
Receipt number R000047959
Scientific Title A study for evaluating the effects of intake of food containing lactic acid bacteria on immunological functions - A randomized, single-blind, placebo-controlled trial.
Date of disclosure of the study information 2020/10/13
Last modified on 2021/10/21 14:58:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study for evaluating the effects of intake of food containing lactic acid bacteria on immunological functions - A randomized, single-blind, placebo-controlled trial.

Acronym

A study for evaluating the effects of intake of food containing lactic acid bacteria on immunological functions.

Scientific Title

A study for evaluating the effects of intake of food containing lactic acid bacteria on immunological functions - A randomized, single-blind, placebo-controlled trial.

Scientific Title:Acronym

A study for evaluating the effects of intake of food containing lactic acid bacteria on immunological functions.

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effects of food containing lactic acid bacteria on immunological functions.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

IgA flow rate of saliva

Key secondary outcomes

Conditioning questionnaire, concentration of IgA in saliva, saliva flow rate


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Food containing lactic acid bacteria for 8 weeks

Interventions/Control_2

Placebo (not containing lactic acid bacteria) for 8 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Males and females from 20 to 59 years of age
(2) Subjects giving written informed consent

Key exclusion criteria

(1) Individuals taking antiflatulents and/or laxatives (including purgative drug) and/or drugs which may affect immune function in common use
(2) Individuals taking antibiotics and/or drugs which may affect digestion and absorption in common use
(3) Individuals taking excessive amounts of foods containing lactic acid bacteria, bifidobacteria, natto bacteria, and/or other health foods including food for specified health use and food with function claim, which influence immune function
(4) Individuals presenting known food allergy
(5) Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period
(6) Individuals who have previous and/or current medical history of diseases (e.g., diabetes, liver disease, kidney disease, kidney disease) and/or immune-mediated diseases (e.g., atopic dermatitis, asthma, autoimmune disease)
(7) Individuals who are under treatment or have a history of drug/alcohol dependence
(8) Individuals who participate in other clinical studies or who are in willing to participate to these studies using foods, drugs and/or cosmetics
(9) Individuals who are judged as unsuitable for the study by the investigator for the other reasons

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Tomonori
Middle name
Last name Ando

Organization

Lotte Co., Ltd.

Division name

Central Laboratory, Food material development section

Zip code

336-8601

Address

1-1, Numakage-3chome, Minami-ku, Saitama

TEL

048-837-0187

Email

andou_tomonori@lotte.co.jp


Public contact

Name of contact person

1st name Tomonori
Middle name
Last name Ando

Organization

Lotte Co., Ltd.

Division name

Central Laboratory , Food material development section

Zip code

336-8601

Address

1-1, Numakage-3chome, Minami-ku, Saitama

TEL

048-837-0187

Homepage URL


Email

andou_tomonori@lotte.co.jp


Sponsor or person

Institute

Lotte Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

Lotte Co., Ltd.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Communittee

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo

Tel

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 10 Month 08 Day

Date of IRB

2020 Year 08 Month 17 Day

Anticipated trial start date

2020 Year 10 Month 14 Day

Last follow-up date

2020 Year 10 Month 16 Day

Date of closure to data entry

2020 Year 10 Month 16 Day

Date trial data considered complete

2020 Year 10 Month 16 Day

Date analysis concluded

2020 Year 11 Month 06 Day


Other

Other related information



Management information

Registered date

2020 Year 10 Month 06 Day

Last modified on

2021 Year 10 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047959


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name